Patients Treated
Ages Served
Infusions Conducted
Managing Depression
40 experienced total resolution of depression for a period of time.
30 had reduced depressive symptoms by at least 50%.
14 noticed benefits, even if mood scores changed <50%.
16 experienced no benefit, or discontinued care.
Note: Ember tracks patient wellbeing through protocolized PHQ-9 mood survey tracking and qualitative inputs.
All of the patients we treat at Ember come to us with a diagnosis of depression. Each of their stories is unique and personal.
Patients in our care have maintained continuous relief for 6+ years.
In the two weeks after a patient completes the initial foundation series, we assess treatment response through a combination of three elements: a patient’s quantitative response to the PHQ9 surveys, the patient’s qualitative feedback, and the independent assessment of their mental health providers. Taken together, these inputs provide a full picture of a patient’s response to treatment and give us confidence about their ketamine care plan moving forward.
At Ember Health, we use PHQ-9 surveys to track each patient’s mood as they progress through care with us. This is a self-report test with nine questions that can each score from 0 – 3 points, depending on the frequency of depressive symptoms. The final score can range from 0 (which indicates complete lack of depressive symptoms) to 27 (which is the most severe score). While there is no perfect way to measure or quantify depression, we use the PHQ-9 as it is among the most widely recognized measurement based outcomes tools.
We ask each patient to fill out this mood survey at multiple increments throughout the Foundation, and it plays a central role in determining treatment response, alongside qualitative feedback and provider input.
We send the PHQ-9 survey electronically every two weeks to patients who are actively in our care. Our team monitors inputs daily, and monitor for shifts in mood that would suggest depressive symptoms are recurring and it may be time for a booster infusion.
Our objective is to ensure that our patients maintain the baseline established during the foundational period of care. We monitor symptoms, as indicated through bi-weekly PHQ-9 survey data, and help patients to notice tell tale signs of the return of depressive symptoms to help them determine when to book booster infusions.
Unfortunately, there are no predictors to know how long someone will maintain the benefits of care. With that said, we do know that engaging in healthful activities such as therapy, mindfulness, exercise, and key structural changes can help extend the duration of benefit between sessions.